title: Epstein-Barr virus associated pneumonia in an adult patient with severe aplastic anaemia: resolution after the transient withdrawal of cyclosporine.
authors.forename: Leonardo
authors.initials: L
authors.lastname: Potenza
authors.forename: Patrizia
authors.initials: P
authors.lastname: Barozzi
authors.forename: Mauro
authors.initials: M
authors.lastname: Codeluppi
authors.forename: Monica
authors.initials: M
authors.lastname: Morselli
authors.forename: Fabio
authors.initials: F
authors.lastname: Forghieri
authors.forename: Francesco
authors.initials: F
authors.lastname: Volzone
authors.forename: Giovanni
authors.initials: G
authors.lastname: Riva
authors.forename: Paola
authors.initials: P
authors.lastname: Pietrosemoli
authors.forename: Monica
authors.initials: M
authors.lastname: Pecorari
authors.forename: Giovanna
authors.initials: G
authors.lastname: Leonardi
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Torelli
authors.forename: Mario
authors.initials: M
authors.lastname: Luppi
mesh_terms: D000328:Adult; D000741:Anemia, Aplastic / Q000150:complications / Q000188:drug therapy*; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D020031:Epstein-Barr Virus Infections / Q000209:etiology*; D004854:Herpesvirus 4, Human / Q000502:physiology; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D011024:Pneumonia, Viral / Q000209:etiology*; D012074:Remission Induction; D013601:T-Lymphocytes; D014766:Viremia / Q000209:etiology*; D014775:Virus Activation
chemical_list: D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine